UNSPSC 51362305: Metoserpate hydrochloride

This classification denotes a sedative and hypnotic with the molecular formula C24H32N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KBO7409339, chemically known as 3.beta., 20.alpha.-yohimban-16.beta.-carboxylic acid, 11,17.alpha., 18.alpha.-trimethoxy-, methyl ester, monohydrochloride but more generally known as metoserpate hydrochloride, which bears US NIH Compound Identifier 14443. Most nations, for tariff and trade purposes, schedule metoserpate hydrochloride under HS 29399900 and SITC 54149.

As of Q4 2014, METOSERPATE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Metoserpate hydrochloride bears US NLM identifiers UMLS ID C0521930 and NCI Concept Code C76955. SMILES: COC1CCC2C(C1)[NH]C3C2CCN4[C@@H]3C[C@H]5[C@@H](C4)C[C@@H]([C@@H]([C@H]5C(=O)OC)OC)OC.CL.

UNSPSC 51362305 Metoserpate hydrochloride is a Commodity code that captures pharmaceutical product procurement by state and local health agencies, though the recent solicitation activity under this code bears little direct relation to metoserpate itself. State and local buyers use this code's taxonomy to source generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, direct-to-manufacturer programs, and routine acquisitions by county health departments. The solicitations show health agencies procuring naloxone, generic pharmaceuticals, and drug deactivation systems as part of broader community health, pharmacy benefit, and emergency response initiatives. Issuing bodies include state health and human services departments, county health systems, and multistate cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and the Texas Health and Human Services Commission are active procurers in this space, and Seminole County, Florida has posted recent needs for naloxone and deactivation systems.

Recent activity concentrates in Texas, Florida, and Minnesota. The Minnesota Department of Administration issued an RFP through MMCAP on January 20, 2026, with a March 26, 2026 response deadline, seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution to state and local facilities across Minnesota and Oregon, with contracts effective July 1, 2026; vendors must maintain relationships with authorized wholesalers AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC, comply with cGMP and Drug Supply Chain Security Act standards, and accept a 3 percent administrative fee. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, bid deadline July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in early April 2026 to gather vendor capabilities on a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, an exploratory phase preceding formal procurement. The code shows activity but limited recent opportunities directly matching metoserpate as a named product.